Samen werken, voor een psychisch gezonde jeugd

Zoeken
Generic filters
Exact matches only

Bronnen

van Aerde, K.J., Kalverdijk, L.J., Reimer, A.G., Widdershoven, J.A. (2008). QT interval prolongation and psychotropic drugs in children and adolescents: proposed quideline. Nederlands Tijdschrift voor Geneeskunde; 152(32): 1765-70.

Biederman, J., Spencer, T.J., Monuteaux, M.C. et al. (2010). A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects.  Journal of Pediatrics. 157(4):635-40.

Cahn, W., Ramlal, D., Bruggeman, R., de Haan, L., Scheepers, F.E., van Soest, M.M., Assies, J., Slooff, C.J. (2008). Preventie en behandeling van somatische complicaties bij antipsychoticagebruik. Tijdschrift voor Psychiatrie; 50(9): 579-591.

Correl, C.U. (2007). Weight Gain and Metabolic Effects of Mood Stabilizers and Antipsychotics in Pediatric Bipolar Disorder: A Systematic Review and Pooled Analysis of Short-Term Trials. JAACAP; 46: 687-700.

Devinsky, O., Honigfeld, G., Patin, J.(1991). Clozapine-related seizures. Neurology; 41(3):369-371.

Efron, D., Jarman, F., Barker, M. (1997a). Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Pediatrics; 100(6): E6.

Efron, D., Jarman, F., Barker, M. (1997b) Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics; 100(4): 662-666.

Faraone, S.V., Biederman, J., Morley, C.P., Spencer, T.J. (2008). Effect of stimulants on height and weight: a review of the literature. JAACAP; 47(9): 994-1009.

Faraone, S., Buitelaar, J. (2010) Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. European Child & Adolescent Psychiatr; 19(4):353-64.

Findling, R.L., Robb, A., Nyilas, M., Forbes, R.A., Jin, N., Ivanova, S., Marcus, R., McQuade, R.D., Iwamoto, T., Carson, W.H. (2008). A multiple-center, randomized, double blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. American Journal of Psychiatry; 165(11): 1432-41.

Friedman, R.A., Leon, A.C. (2007). Expanding the black box – depression, anti-depressants and the risk of suicide. The New England Journal of Medicine; 356(23): 2343-6.

Gilbert, D.L., Batterson, J.R., Sethuraman, G., Sallee, F.R. (2004). Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. JAACAP; 43(2): 206-214.

Greenhill, L., Kollins, S., Abikoff, H. et al. (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. JAACAP; 45: 1284-1293.

Gründer, G., Carlsson, A., & Wong, D.F. (2003). Mechanism of New Antipsychotic Medications: Occupancy Is Not Just Antagonism. Archives of General Psychiatry60(10), 974 -977.

Gutgesell, H., Atkins, D., Barst, R., Buck, M., Franklin, W., Humes, R. et al. (1999). Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation; 99(7): 979-982.

Malone, R.P., Maislin, G., Choudhury, M.S., Gifford, C., Delaney, M.A. (2002). Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness. JAACAP; 41(2): 140-147

Mannuzza, S., Klein, R., Truong, N. et al. (2008). Age of Methylphenidate Treatment Initiation in Children With ADHD and Later Substance Abuse: Prospective Follow-Up Into Adulthood. American Journal of Psychiatry; 165:604–609.

Olfson, M., Huang, C., Gerhardt, T. et.al. (2012). Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. JAACAP; 51(2) 147-56.

Vorstman, J., Lahuis, B., Buitelaar, J.K. (2001). SSRIs associated with behavioral activation and suicidal ideation. JAACAP; 40(12): 1364-1365

Ruth, U., Mayer-Rosa, J., Schlamp, D., Freisleder, F.J. (2000). Tourette´s syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine. Zeitschrift fur Kinder-undJugendpsychiatrie und Psychotherapie; 28(2): 105-108

Richardson, G., Wang-Weigand, S. (2009) Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. Human Psychopharmacology; 24(2): 103-11.

Schubiner, H., Saules, K.K., Arfken, C.L., Johanson, C.E., Schuster, C.R., Lockhart, N. et al. (2002). Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology; 10(3): 286-294

Westermann, G.M.A., McGregor-Schuerman, M.M.I.L., Langenaken, M.J.M.C. et al. (2013) Antipsychotica, overgewicht en metabole afwijkingen bij kinderen en jeugdigen. Psyfar;8(2): 10-18.

Wilens, T.E., Biederman, J., Baldessarini, R.J., Geller, B., Schleifer, D., Spencer, T.J. et al. (1996). Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. JAACAP; 35(11): 1491-1501.

    Het Kenniscentrum Kinder- en Jeugdpsychiatrie maakt gebruik van cookies voor analyse van het gebruik van deze website en om de website optimaal te laten werken. Jouw bezoek blijft daarbij anoniem. Voor meer informatie, zie onze privacyverklaring

    Deze site is standaard ingesteld op 'cookies toestaan", om je de beste mogelijke blader ervaring te geven. Als je deze site blijft gebruiken zonder je cookie instellingen te wijzigen, of als je klikt op "Accepteren" hieronder, dan geef je toestemming voor het gebruik van Cookies.

    Sluiten